Detalhe da pesquisa
1.
Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia.
Nephrol Dial Transplant
; 37(8): 1461-1471, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383954